Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters











Publication year range
2.
Genet Couns ; 12(2): 137-43, 2001.
Article in English | MEDLINE | ID: mdl-11491308

ABSTRACT

The authors report on a female infant with partial trisomy 9 (pter-->q12) together with partial monosomy 22 (pter-->q11.23) that included DiGeorge critical region (DGCR), as a result of adjacent-2 disjunction. In addition to the clinical features characteristic of trisomy 9p syndrome, the patient had Truncus arteriosus type A2, bilateral hydronephrosis, palatal anomaly, retrognathia, and laryngeal hypotonia, which are likely to be attributed to 22q11.2 deletion. This patient appears to be the first reported case with such unbalanced translocation resulting from a paternal reciprocal translocation. For live birth, the risk for male carrier is 8.7-17.4%. It is important to consider this higher risk when counseling. Precise study concerning the presence of the DGCR can facilitate in the better understanding of the condition.


Subject(s)
Abnormalities, Multiple/genetics , Chromosomes, Human, Pair 22 , Chromosomes, Human, Pair 9 , Translocation, Genetic , Trisomy , Female , Humans , In Situ Hybridization, Fluorescence , Infant , Karyotyping , Syndrome
3.
Carbohydr Res ; 330(4): 439-43, 2001 Feb 28.
Article in English | MEDLINE | ID: mdl-11269395

ABSTRACT

Alpha-Neup5Ac-(2-->6)-D-GalpNAc, the carbohydrate portion of sialyl-Tn epitope of the tumor-associated carbohydrate antigen, was prepared by a whole-cell reaction through the combination of recombinant Escherichia coli strains and Corynebacterium ammoniagenes. Two recombinant E. coli strains overexpressed the CMP-Neup5Ac biosynthetic genes and the alpha-(2-->6)-sialyltransferase gene of Photobacterium damsela. C. ammoniagenes contributed to the production of UTP from orotic acid. Alpha-Neup5Ac-(2-->6)-D-GalpNAc was accumulated at 87 mM (45 g/L) after a 25-h reaction starting from orotic acid, N-acetylneuraminic acid, and 2-acetamide-2-deoxy-D-galactose.


Subject(s)
Antigens, Tumor-Associated, Carbohydrate/biosynthesis , Epitopes/biosynthesis , Acetylgalactosamine/metabolism , Antigens, Tumor-Associated, Carbohydrate/chemistry , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Carbohydrate Conformation , Carbohydrate Sequence , Carbon-Nitrogen Ligases/genetics , Carbon-Nitrogen Ligases/metabolism , Corynebacterium/metabolism , Escherichia coli/metabolism , Industrial Microbiology , Molecular Sequence Data , N-Acetylneuraminic Acid/metabolism , Nuclear Magnetic Resonance, Biomolecular , Orotic Acid/metabolism , Photobacterium/genetics , Recombinant Fusion Proteins/metabolism , Sialyltransferases/genetics , Sialyltransferases/metabolism , beta-D-Galactoside alpha 2-6-Sialyltransferase , beta-Galactoside alpha-2,3-Sialyltransferase
6.
Carbohydr Res ; 316(1-4): 179-83, 1999 Mar 31.
Article in English | MEDLINE | ID: mdl-10420596

ABSTRACT

A large-scale production system of N-acetyllactosamine, a core structure of various oligosaccharides, was established by a whole-cell reaction through the combination of recombinant Escherichia coli strains and Corynebacterium ammoniagenes. Two recombinant E. coli strains over-expressed the UDP-Gal biosynthetic genes and the beta-(1-->4)-galactosyltransferase gene of Neisseria gonorrhoeae, respectively. C. ammoniagenes contributed the production of UTP from orotic acid. N-Acetyllactosamine was accumulated at 279 mM (107 g L-1) after a 38 h reaction (2.5 L in volume) starting from orotic acid, D-galactose, and 2-acetamido-2-deoxy-D-glucose.


Subject(s)
Amino Sugars/biosynthesis , Acetylglucosamine/metabolism , Corynebacterium/metabolism , Escherichia coli/metabolism , Galactokinase/genetics , Galactokinase/metabolism , Galactose/metabolism , Galactosyltransferases/genetics , Galactosyltransferases/metabolism , Orotic Acid/metabolism , Pyrophosphatases/genetics , Pyrophosphatases/metabolism , Recombinant Fusion Proteins/metabolism , UTP-Glucose-1-Phosphate Uridylyltransferase/genetics , UTP-Glucose-1-Phosphate Uridylyltransferase/metabolism , UTP-Hexose-1-Phosphate Uridylyltransferase/genetics , UTP-Hexose-1-Phosphate Uridylyltransferase/metabolism
9.
Avian Dis ; 39(2): 218-29, 1995.
Article in English | MEDLINE | ID: mdl-7677642

ABSTRACT

Since 1990, highly virulent infectious bursal disease virus (IBDV), which induces high mortality, has been infecting even vaccinated flocks in Japan. We report the efficacy of three live vaccines that are available in Japan. Two mildly attenuated strains (A and B) and one intermediate strain (C) were each tested both in specific-pathogen-free (SPF) chickens and in commercial chickens that have maternal antibodies against IBDV. Chickens were vaccinated at 20 days old and challenged with highly virulent IBDV 10 days post-vaccination. Protection was determined 7 days after challenge by measuring bursa/body weight ratios, histopathological lesions, and antibody responses to IBDV. All three lie vaccines conferred protection to SPF chickens. However, only vaccine C protected 100% of vaccinated commercial chickens against highly virulent IBDV; Vaccines A and B respectively protected three-fourths and none of vaccinated commercial chickens from severe bursal lesions. Vaccines A, B, and C and highly virulent IBDV induced bursal lesions in 3%, 0%, 23%, and 61% of inoculated commercial chickens, respectively. These results suggest that serological determination of the optimum vaccination time for each flock is required to effectively control highly virulent IBDV in the field. The optimum vaccination timing could be approximated by titrating the maternal IBDV antibodies of 1-day-old chicks by an enzyme-linked immunosorbent assay or by an agar gel precipitin test.


Subject(s)
Birnaviridae Infections/veterinary , Chickens , Infectious bursal disease virus/immunology , Poultry Diseases/prevention & control , Viral Vaccines/administration & dosage , Animals , Antibodies, Viral/biosynthesis , Antibodies, Viral/immunology , Birnaviridae Infections/immunology , Birnaviridae Infections/prevention & control , Body Weight , Chickens/growth & development , Chickens/immunology , Enzyme-Linked Immunosorbent Assay/veterinary , Poultry Diseases/virology , Species Specificity , Time Factors , Vaccines, Attenuated/administration & dosage , Vaccines, Attenuated/immunology , Viral Vaccines/immunology
11.
J Vet Med Sci ; 54(1): 99-103, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1313708

ABSTRACT

The efficacy of the albumen test for infectious avian leukosis virus (ALV) was examined in detecting congenitally transmitting hens. Seventy-three White Leghorn non-viremic hens with antibody to ALV were used. Eleven of the hens shed infectious ALV into their egg albumen, whereas only 7 of the 11 ALV-positive hens shed ALV antigens. The egg albumen test for infectious ALV was shown to be more effective in detecting the congenitally transmitting hens than that for ALV antigens. Then, twenty of the 62 hens which shed no infectious ALV into the albumen were studied for transmission of ALV to their embryos and for discharging ALV into the oviduct and vagina. Six of the 50 embryos from 4 hens were found to be infected with ALV but all of the 227 embryos from remaining 16 hens were free from the infection. Discharge of the virus into the oviduct and vagina was found both in the 4 transmitting hens and in 6 of the 16 non-transmitting hens. These results suggest that the hens discharging ALV into the oviduct, even though they do not shed ALV into egg albumen, may transmit the virus sporadically to their embryos.


Subject(s)
Avian Leukosis Virus/physiology , Avian Leukosis/transmission , Chickens , Egg White/microbiology , Oviducts/microbiology , Animals , Antibodies, Viral/blood , Antigens, Viral/analysis , Avian Leukosis/congenital , Avian Leukosis Virus/immunology , Chick Embryo/microbiology , Enzyme-Linked Immunosorbent Assay , Female , Vagina/microbiology
12.
J Biol Chem ; 267(4): 2157-63, 1992 Feb 05.
Article in English | MEDLINE | ID: mdl-1733924

ABSTRACT

We have found that a fungal strain, Talaromyces wortmannin KY12420, produces a potent inhibitor of smooth muscle myosin light chain kinase (MLCK). This active product, designated as MS-54, was isolated and purified from the culture broth of the fungus and identified as wortmannin. The inhibition of MLCK by wortmannin was prevented by a high concentration of ATP. The activity of the catalytic domain, which was disclosed by partial tryptic digestion, was also inhibited by wortmannin. These results suggest that wortmannin acts at or near to the catalytic site of the enzyme. It was shown clearly by kinetic analyses, preincubation studies, and dialysis experiments that the inhibitory action of wortmannin on MLCK was irreversible. Under the condition of preincubation for 3 min, 0.3 microM wortmannin inhibited the activity of MLCK, while 10 microM wortmannin had no effect on the activities of cAMP-dependent protein kinase, cGMP-dependent protein kinase, and calmodulin-dependent protein kinase II, and had little effect on protein kinase C activity. These data expressed clearly the marked selectivity of the compound for MLCK. Furthermore, wortmannin also inhibited both the phosphorylation of myosin light chain and the contraction in rat thoracic aorta stimulated with KCl, which indicates the effectiveness of the compound in the cellular level as an MLCK inhibitor.


Subject(s)
Androstadienes/pharmacology , Ascomycota/metabolism , Myosin-Light-Chain Kinase/antagonists & inhibitors , Adenosine Triphosphate/metabolism , Amino Acid Sequence , Androstadienes/isolation & purification , Animals , Blotting, Western , Brain/enzymology , Cattle , Chickens , Electrophoresis, Polyacrylamide Gel , Gizzard, Avian/enzymology , Kinetics , Male , Molecular Sequence Data , Muscle Contraction/drug effects , Muscle, Smooth, Vascular/drug effects , Muscle, Smooth, Vascular/physiology , Phosphorylation/drug effects , Protein Kinases/metabolism , Rats , Rats, Inbred Strains , Wortmannin
13.
J Vet Med Sci ; 53(5): 859-64, 1991 Oct.
Article in English | MEDLINE | ID: mdl-1661176

ABSTRACT

A total of 72 White Leghorn grandparent hens was examined by ELISA for avian leukosis virus (ALV), ALV antigens and anti-ALV antibodies to identify and characterize the hens transmitting ALV to their embryos (transmitters) by using fertilized eggs. These hens were divided into 3 groups as no antibody and non-viremic (NANV) (49 hens), antibody-positive and non-viremic (APNV) (21 hens) and no antibody and viremic (NAV) (2 hens) by testing the sera for the presence of ALV and anti-ALV antibody. Egg albumen and embryos were tested for the presence of ALV and ALV antigens. As a result, no ALV was detected in both albumen and embryos in the NANV group. On the other hand, all albumen samples collected repeatedly from 3 hens of the APNV group and 2 hens of the NAV group contained infectious ALV, although the infectivity differed with the individual. Also, these 5 hens produced infected embryos at varying frequencies. However, on AP hen which shed neither ALV nor ALV antigens into the albumen produced an infected embryo at a lower rate. These results indicate that testing for infectious ALV in albumen from a newly laid egg per hen is effective to identify the transmitters to some extent. When virus titers in each of 8 tissue samples from the 6 transmitting hens were determined, the highest virus titers were found in washing from the ampulla of the oviducts in most of the shedders, suggesting that embryo infection is closely correlated with ALV produced at the oviduct, but not with ALV transferred from the other parts of the body.


Subject(s)
Antibodies, Viral/blood , Antigens, Viral/analysis , Avian Leukosis Virus/isolation & purification , Avian Leukosis/diagnosis , Chickens , Animals , Avian Leukosis/transmission , Avian Leukosis Virus/immunology , Chick Embryo/microbiology , Egg White/microbiology , Enzyme-Linked Immunosorbent Assay , Female , Male , Oviducts/microbiology , Viremia/diagnosis , Viremia/veterinary
14.
Biochem Med ; 34(2): 176-81, 1985 Oct.
Article in English | MEDLINE | ID: mdl-3910032

ABSTRACT

In order to elucidate the effects of aging on insulin content in human pancreas, the immunoelectrophoretic analysis of insulin was applied. The pancreas of senile humans appears to contain less total immunoreactive insulin, because of the decrement of proinsulin fraction after overnight fasting. The results suggest the involvement of insulin biosynthesis according to the aging process.


Subject(s)
Aging , Insulin/biosynthesis , Adult , Aged , Arginine/analogs & derivatives , Arginine/analysis , Blood Glucose/analysis , Blood Proteins/analysis , Fasting , Humans , Immunoelectrophoresis , Insulin/analogs & derivatives , Insulin/analysis , Islets of Langerhans/metabolism , Middle Aged , Proinsulin/analysis
15.
J Chromatogr ; 222(1): 33-40, 1981 Jan 02.
Article in English | MEDLINE | ID: mdl-7012165

ABSTRACT

The immunoreactivity of circulating C-peptide is separated into two main peaks on a Bio-Gel column; the faster peak should not be proinsulin but an associated C-peptide without a covalent bond. Proinsulin is in fact eluted in the fraction prior to the faster eluting peak of C-peptide immunoreactivity with 1 M acetic acid as the eluting buffer. Therefore the use of gel chromatography to study C-peptide and proinsulin needs to be carefully re-evaluated, although the method has been established as one of the standard methods.


Subject(s)
C-Peptide/isolation & purification , Peptides/isolation & purification , Proinsulin/isolation & purification , Chromatography, Gel/methods , Glucose Tolerance Test , Humans , Indicator Dilution Techniques , Insulin Antibodies/analysis
SELECTION OF CITATIONS
SEARCH DETAIL